According to Ironwood Pharmaceuticals 's latest financial reports the company's total assets are $0.43 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.47 B | -57.2% |
2022-12-31 | $1.10 B | -2.34% |
2021-12-31 | $1.12 B | 101.51% |
2020-12-31 | $0.55 B | 38.86% |
2019-12-31 | $0.40 B | 21.29% |
2018-12-31 | $0.33 B | -45.18% |
2017-12-31 | $0.60 B | -14.67% |
2016-12-31 | $0.70 B | 14.65% |
2015-12-31 | $0.61 B | 88% |
2014-12-31 | $0.32 B | 18.05% |
2013-12-31 | $0.27 B | 21.34% |
2012-12-31 | $0.22 B | 10.02% |
2011-12-31 | $0.20 B | -30.66% |
2010-12-31 | $0.30 B | 85.51% |
2009-12-31 | $0.16 B | 17.4% |
2008-12-31 | $0.13 B | 1.81% |
2007-12-31 | $0.13 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
AstraZeneca AZN | $102.29 B | 23,210.98% | ๐ฌ๐ง UK |
Nektar Therapeutics
NKTR | $0.39 B | -9.76% | ๐บ๐ธ USA |